New Class of HIV Integrase Inhibitors that Block Viral Replication in Cell Culture
Christophe Pannecouque(Rega Institute for Medical Research), Zeger Debyser(KU Leuven), Bénédicte Van Maele(Rega Institute for Medical Research), Erik De Clercq(Rega Institute for Medical Research), Peter Cherepanov(The Francis Crick Institute), Wim Pluymers(Rega Institute for Medical Research), Myriam Witvrouw(Rega Institute for Medical Research), Victor Tetz(First Pavlov State Medical University of St. Petersburg)
Cited by 100
Related Papers
Therapeutic strategies for COVID-19: progress and lessons learned
|Nature Reviews Drug Discovery|2023|671
Antiviral agents active against influenza A viruses
|Nature Reviews Drug Discovery|2006|666
Effect of DNase and Antibiotics on Biofilm Characteristics
|Antimicrobial Agents and Chemotherapy|2008|403
The structural biology of HIV-1: mechanistic and therapeutic insights
|Nature Reviews Microbiology|2012|395
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
|Science Advances|2021|161